Urinary clusterin levels have been found to be significantly increased in patients with T2DM compared to control groups, and this has been associated with the annual decline in the estimated glomerular filtration rate (eGFR) and the progression of DN stage [62]. The gene discussed is CLU; the disease is type 2 diabetes mellitus.